Getinge, Medtronic and LivaNova PLC Industries – Notable Market Participants in Perfusion Systems Market
The perfusion systems market is highly competitive in nature with considerable number of players, having a high level of consolidation overall revenue share. Most of the companies operating in the perfusion systems market are present globally and have wide distribution and sales network through partnerships or authorized dealers.
The most notable perfusion systems market participants are REPLIGEN CORPORATION, Merck KGaA, Ala Scientific Instruments, Inc., XVIVO Perfusion, Medtronic, XENIOS AG (Fresenius Medical Care AG & Co. KGaA), Getinge AB, TERUMO CORPORATION, LivaNova PLC, Sartorius AG, Harvard Bioscience, RAND, Sanisure (Sani-Tech West, Inc.), AutoMate Scientific, Inc., Jobst Technologies GmbH, APD (Advanced Perfusion Diagnostics), Spectrum Medical, Transonic Systems Inc, OrganOx, ISCHEMAVIEW, INC, and CESCO BIOENGINEERING CO., LTD. occupying a considerable share of the market owing to their offerings to the market.
Market leaders are involved in providing the products and systems that contribute to quality enhancement and cost efficiency within healthcare and life sciences. For instance, in May 2017, Merck launched the EX-CELL Advanced HD Perfusion Medium, which is the first off-the-shelf, high-density cell culture media supports perfusion processes at low perfusion rates, increasing production yield and speed to clinic.
Many well-known as well as small local companies are present in the market to provide diversified products to its customers. The larger firms are adopting the strategy of acquiring small firms to enhance its product portfolio and expand its footprint in different geographies. Additionally various companies are also undergoing other strategic alliances such as acquisitions and others to garner their significance and remain competitive in the perfusion systems market. Few on the important key developments from the industry are mentioned below:
| Year | News | Region |
| 2018 | XVIVO Perfusion has submitted the Premarket Approval (PMA) application for the XPS with STEEN Solution to the FDA | Europe |
| 2018 | Sartorius Stedim Biotech (Sartorius AG) partnered with Repligen to create a single control system for 50 L to 2,000 L bioreactors used in perfusion cell culture applications. | Europe |
| 2016 | SaniSure, the premier global suppliers of solution based single use systems opened a significant capacity expansion with the acquisition of a second facility in Camarillo, Ca. | North America |
